AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20238203 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in an onlay position
Number of subjects: 0
Study 20238203 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in a sublay position
Number of subjects: 0
Study 20238203 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in an intraperitoneal onlay position
Number of subjects: 0
Study 17341394 — intervention group
Group type: EXPERIMENTAL
Intervention: New left bundle branch block (LBBB)
Number of subjects: 14703
Study 17341394 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 14703
Study 17341394 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 14703
Study 17341394 — intervention group
Group type: COMPARATOR
Intervention: Both valsartan and captopril
Number of subjects: 14703
Study 16262739 — intervention group
Group type: EXPERIMENTAL
Intervention: PermaNet 1.0
Number of subjects: 177
Study 16262739 — intervention group
Group type: EXPERIMENTAL
Intervention: Insector
Number of subjects: 177
Study 16262739 — intervention group
Group type: EXPERIMENTAL
Intervention: Olyset
Number of subjects: 177
Study 16262739 — intervention group
Group type: EXPERIMENTAL
Intervention: Dawa
Number of subjects: 177
Study 16262739 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclodextrin-treated nets
Number of subjects: 177
Study 16262739 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyester bednets treated with deltamethrin
Number of subjects: 177
Study 12040355 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate at 0.1 microg/kg/min
Number of subjects: 45
Study 12040355 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (1/2 NS)
Number of subjects: 45
Study 12040355 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate
Number of subjects: 45
Study 12040355 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (1/2 NS) in patients with diabetes
Number of subjects: 45
Study 12040355 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate in patients with diabetes
Number of subjects: 45
Study 10069278 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium (groups 1 and 2)
Number of subjects: 79
Study 10069278 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium (groups 3 and 4)
Number of subjects: 79
Study 8625180 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy, 60 Gy in 6 weeks (radiotherapy group)
Number of subjects: 267
Study 8625180 — intervention group
Group type: EXPERIMENTAL
Intervention: Three courses of postoperative COPAC chemotherapy followed by similar radiotherapy schedule (chemotherapy/radiotherapy group)
Number of subjects: 267
Study 2044419 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine sonography at postoperative days 1, 3, 7, and 9
Number of subjects: 300
Study 2044419 — intervention group
Group type: COMPARATOR
Intervention: Sonography on demand
Number of subjects: 300
Study 6797085 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol agents (specific agents not detailed)
Number of subjects: 0
Study 6797085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6797085 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasympathetic system blocker
Number of subjects: 0
Study 6797085 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta 2 adrenergic stimulation
Number of subjects: 0
Study 6797085 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 0
Study 6797085 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine-induced bronchial hyperreactivity
Number of subjects: 0
Study 30719237 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 155
Study 30719237 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 155
Study 30719237 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 155
Study 27989690 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (40mg daily for six weeks)
Number of subjects: 44
Study 27989690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 25496958 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS applied to the left dorsolateral prefrontal cortex (dlPFC) during a Go/No-Go test
Number of subjects: 0
Study 25496958 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 0
Study 25233656 — intervention group
Group type: EXPERIMENTAL
Intervention: Hegu 1 group
Number of subjects: 50
Study 25233656 — intervention group
Group type: EXPERIMENTAL
Intervention: Hegu 2 group
Number of subjects: 50
Study 25233656 — intervention group
Group type: EXPERIMENTAL
Intervention: Hegu 3 group
Number of subjects: 50
Study 25233656 — intervention group
Group type: EXPERIMENTAL
Intervention: Hegu 4 group
Number of subjects: 50
Study 25233656 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 22586334 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoked cannabis (once daily for three days)
Number of subjects: 37
Study 22586334 — intervention group
Group type: COMPARATOR
Intervention: Identical placebo cigarettes (once daily for three days)
Number of subjects: 37
Study 20853602 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside in high doses (first and second course)
Number of subjects: 631
Study 20853602 — intervention group
Group type: COMPARATOR
Intervention: Standard induction courses
Number of subjects: 631
Study 20853602 — intervention group
Group type: EXPERIMENTAL
Intervention: HAM course as the second induction course
Number of subjects: 631
Study 20853602 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive therapy
Number of subjects: 631
Study 20853602 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 631
Study 20853602 — intervention group
Group type: COMPARATOR
Intervention: Induction courses
Number of subjects: 631
Study 20853602 — intervention group
Group type: EXPERIMENTAL
Intervention: Current AML treatment programs
Number of subjects: 631
Study 17984737 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (375 mg infusion)
Number of subjects: 141
Study 17984737 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 141
Study 15338100 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 2.5 mg
Number of subjects: 100
Study 15338100 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 100
Study 15338100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 15338100 — intervention group
Group type: EXPERIMENTAL
Intervention: Final challenge with diazepam
Number of subjects: 100
Study 15338100 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment with diazepam
Number of subjects: 100
Study 15338100 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD status
Number of subjects: 100
Study 12191668 — intervention group
Group type: EXPERIMENTAL
Intervention: Total etching + two coats of single bond (SB) + composite resin (Z‐100)
Number of subjects: 18
Study 12191668 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel etching + two coats of SB + Z‐100
Number of subjects: 18
Study 12191668 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavity floor lined with calcium hydroxide liner (Dycal) + acid‐etching of enamel and lateral walls + two coats of SB + Z‐100
Number of subjects: 18
Study 12191668 — intervention group
Group type: COMPARATOR
Intervention: Intact control group (two teeth)
Number of subjects: 18
Study 9791745 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning SSR testing
Number of subjects: 10
Study 9791745 — intervention group
Group type: COMPARATOR
Intervention: Early evening SSR testing
Number of subjects: 10
Study 8561981 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured intervention program (individual counseling with a nurse and six-session support group)
Number of subjects: 271
Study 8561981 — intervention group
Group type: COMPARATOR
Intervention: Community referral group
Number of subjects: 271
Study 8561981 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (structured intervention and community referral)
Number of subjects: 271
Study 2091337 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinine suppositories
Number of subjects: 62
Study 2091337 — intervention group
Group type: COMPARATOR
Intervention: Oral quinine
Number of subjects: 62
Study 7388278 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen with radiotherapy (27 fractions)
Number of subjects: 116
Study 7388278 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (27 fractions)
Number of subjects: 116
Study 31811613 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored couples-based smoking cessation intervention
Number of subjects: 0
Study 31530608 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus intervention (community midwives weighing women, setting weight gain limits, providing feedback)
Number of subjects: 656
Study 31530608 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 656
Study 31530608 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus intervention
Number of subjects: 656
Study 27662551 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pentavalent rotavirus vaccine (RV5)
Number of subjects: 202
Study 27662551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 25572383 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload dependence indices-guided intravascular volume expansion
Number of subjects: 60
Study 25572383 — intervention group
Group type: COMPARATOR
Intervention: Central venous pressure-guided intravascular volume expansion (Control)
Number of subjects: 60
Study 23323672 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRI) added to supportive care
Number of subjects: 0
Study 23323672 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 0
Study 17550491 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg vaginal misoprostol every six hours up to four doses
Number of subjects: 100
Study 17550491 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg vaginal misoprostol every six hours up to four doses
Number of subjects: 100
Study 15474274 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvicol pubovaginal sling
Number of subjects: 142
Study 15474274 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 142
Study 10781464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 5 microg combined with midazolam 1 mg
Number of subjects: 0
Study 8757561 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (8 gm)
Number of subjects: 96
Study 8757561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 1550481 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate 90 minutes before surgery plus intraoperative neural blockade, with a postoperative analgesic regimen with combined bupivacaine hydrochloride‐morphine and indomethacin sodium (group 2)
Number of subjects: 20
Study 1550481 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative pain treatment with morphine chloride and acetaminophen (group 1)
Number of subjects: 20
Study 2863443 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective testicular biopsy during chemotherapy
Number of subjects: 238
Study 2863443 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-therapy testicular biopsy
Number of subjects: 238
Study 2863443 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative biopsy findings 12-28 months before relapse
Number of subjects: 238
Study 31816447 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk Aesthetic Clinical Evaluation (TRACE)
Number of subjects: 1553
Study 30609310 — intervention group
Group type: EXPERIMENTAL
Intervention: MT medialization
Number of subjects: 80
Study 30609310 — intervention group
Group type: COMPARATOR
Intervention: Intact MT
Number of subjects: 80
Study 30609310 — intervention group
Group type: EXPERIMENTAL
Intervention: Patent OC
Number of subjects: 80
Study 30609310 — intervention group
Group type: COMPARATOR
Intervention: Congested OC
Number of subjects: 80
Study 27296243 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversation Therapy (CT)
Number of subjects: 2
Study 27296243 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation Therapy (ST)
Number of subjects: 2
Study 25906556 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross electro‐nape‐acupuncture
Number of subjects: 60
Study 25906556 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 60
Study 23688830 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-guided Internet-delivered cognitive behaviour therapy (iCBT) program (the Pain Course) consisting of 5 lessons, homework tasks, additional resources, and weekly contact from a Clinical Psychologist.
Number of subjects: 63
Study 23688830 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 63
Study 20824758 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 810
Study 20824758 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 810
Study 19474685 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery (GBP)
Number of subjects: 30
Study 19474685 — intervention group
Group type: COMPARATOR
Intervention: Diet
Number of subjects: 30
Study 16765589 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF chemotherapy (cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 771
Study 16765589 — intervention group
Group type: COMPARATOR
Intervention: Goserelin (every 28 days for 2 years)
Number of subjects: 771
Study 16765589 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF chemotherapy
Number of subjects: 771
Study 16765589 — intervention group
Group type: COMPARATOR
Intervention: Goserelin
Number of subjects: 771
Study 15218709 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dentifrice containing 5.5% potassium citrate, 1.14% sodium monofluorophosphate, and 10% high-cleaning silica
Number of subjects: 80
Study 15218709 — intervention group
Group type: COMPARATOR
Intervention: Positive control dentifrice containing 3.75% potassium chloride, 0.32% sodium fluoride, and 0.3% triclosan
Number of subjects: 80
Study 10899409 — intervention group
Group type: EXPERIMENTAL
Intervention: Caucasian dataset with CATD polymorphism
Number of subjects: 210
Study 10899409 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic dataset with CATD polymorphism
Number of subjects: 210
Study 10899409 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregate analysis of published Caucasian datasets
Number of subjects: 210
Study 10023151 — intervention group
Group type: EXPERIMENTAL
Intervention: Polarizing mixture (potassium + insulin + glucose)
Number of subjects: 36
Study 8453222 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic ORS solution (224 mosmol/l)
Number of subjects: 238
Study 8453222 — intervention group
Group type: COMPARATOR
Intervention: Isotonic ORS solution (304 mosmol/l)
Number of subjects: 238
Study 3020732 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplement (MaxEPA) 15 gm per day
Number of subjects: 41
Study 3020732 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 31689510 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with mechanical debridement (MD) (Group-A)
Number of subjects: 0
Study 31689510 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotics (AB) with mechanical debridement (MD) (Group-B)
Number of subjects: 0
Study 31689510 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement alone (MD) (Group-C)
Number of subjects: 0
Study 30301642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-vaccine Exercise (15-minutes upper body exercise)
Number of subjects: 194
Study 30301642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-vaccine Arm, Pre-vaccine Leg, Post-vaccine Arm (15-minutes of arm or leg exercises)
Number of subjects: 194
Study 30301642 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 194
Study 26510574 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy administered to the dorsum of the tongue
Number of subjects: 45
Study 26510574 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with a tongue scraper
Number of subjects: 45
Study 26510574 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with a tongue scraper combined with photodynamic therapy
Number of subjects: 45
Study 24829952 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression-anxiety factor
Number of subjects: 1070
Study 24829952 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual problems due to ADT side effects (breast changes and hot flushes)
Number of subjects: 1070
Study 24829952 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary dysfunction
Number of subjects: 1070
Study 24829952 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression-anxiety
Number of subjects: 1070
Study 21564154 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus usual treatment
Number of subjects: 40
Study 21564154 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 40
Study 21335296 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacy-based falls-prevention program (medication consultation)
Number of subjects: 186
Study 21335296 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication consultation)
Number of subjects: 186
Study 21335296 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacy-based falls-prevention program
Number of subjects: 186
Study 21335296 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 186
Study 18347922 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported history of lobular proliferation (BBD)
Number of subjects: 6926
Study 18347922 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported history of fibroadenoma (BBD)
Number of subjects: 6926
Study 18347922 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported history of other BBD
Number of subjects: 6926
Study 18347922 — intervention group
Group type: COMPARATOR
Intervention: Surgically treated fibroadenoma
Number of subjects: 6926
Study 18347922 — intervention group
Group type: COMPARATOR
Intervention: Surgically treated other BBDs
Number of subjects: 6926
Study 15709083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dislike of school
Number of subjects: 0
Study 15709083 — intervention group
Group type: COMPARATOR
Intervention: Ambivalence to school
Number of subjects: 0
Study 12612387 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol 340 (Niopam)
Number of subjects: 2108
Study 12612387 — intervention group
Group type: EXPERIMENTAL
Intervention: iomeprol 350 (Iomeron)
Number of subjects: 2108
Study 12612387 — intervention group
Group type: EXPERIMENTAL
Intervention: iodixanol 320 (Visipaque)
Number of subjects: 2108
Study 12612387 — intervention group
Group type: COMPARATOR
Intervention: All agents
Number of subjects: 2108
Study 10321505 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 mg of leuprolide acetate every month
Number of subjects: 50
Study 10321505 — intervention group
Group type: COMPARATOR
Intervention: 11.25 mg of leuprolide acetate every 3 months
Number of subjects: 50
Study 8909627 — intervention group
Group type: EXPERIMENTAL
Intervention: BrainPower Program (attribution retraining program)
Number of subjects: 384
Study 8909627 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention training
Number of subjects: 384
Study 8909627 — intervention group
Group type: COMPARATOR
Intervention: No-attention control group
Number of subjects: 384
Study 1958387 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical estimate of ER
Number of subjects: 349
Study 1958387 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran-coated charcoal assay (DCC)
Number of subjects: 349
Study 1958387 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant tamoxifen (TAM) treatment
Number of subjects: 349
Study 6347013 — intervention group
Group type: EXPERIMENTAL
Intervention: Split skin grafting
Number of subjects: 10
Study 6347013 — intervention group
Group type: COMPARATOR
Intervention: Silastic foam dressing (healing by granulation)
Number of subjects: 10
Study 31390370 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability to endometriosis
Number of subjects: 22406
Study 31390370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime smoking exposure
Number of subjects: 22406
Study 31390370 — intervention group
Group type: EXPERIMENTAL
Intervention: Height
Number of subjects: 22406
Study 31390370 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at natural menopause
Number of subjects: 22406
Study 31390370 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability to polycystic ovary syndrome
Number of subjects: 22406
Study 27543681 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Bundle (SB) techniques (n = 12; all-inside arthroscopic inlay, all-inside suspensory fixation, and arthroscopic-assisted open onlay)
Number of subjects: 20
Study 27543681 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-Bundle (DB) techniques (n = 8; arthroscopic-assisted open inlay and all-inside suspensory fixation)
Number of subjects: 20
Study 27543681 — intervention group
Group type: COMPARATOR
Intervention: Intact knees
Number of subjects: 20
Study 26258860 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise training (4-6 months)
Number of subjects: 1188
Study 23943256 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional restorative treatment (CRT) using amalgam
Number of subjects: 302
Study 23943256 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using high-viscosity glass ionomer
Number of subjects: 302
Study 23943256 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraconservative treatment (UCT) protocol
Number of subjects: 302
Study 22873013 — intervention group
Group type: EXPERIMENTAL
Intervention: TND Only
Number of subjects: 1426
Study 22873013 — intervention group
Group type: EXPERIMENTAL
Intervention: TND and motivational interviewing follow‐up
Number of subjects: 1426